Remove Disease Remove Events Remove Radiation
article thumbnail

Adding Metastasis-Directed Radiation Therapy Boosts Progression-Free Survival in Metastatic Pancreatic Cancer

Imaging Technology

5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-directed radiation therapy to standard-of-care chemotherapy improved progression-free survival (PFS) in patients with oligometastatic pancreatic cancer. assistant professor of Gastrointestinal Radiation Oncology. “We

article thumbnail

Dartmouth event bats around promise, shortcomings of AI in healthcare

AuntMinnie

Langlotz's laboratory investigates the use of deep neural networks and other machine-learning technologies to detect disease and eliminate diagnostic errors through analysis of medical images and clinical notes. Photo courtesy of Dartmouth.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Human Lung Chip Leveraged to Faithfully Model Radiation-induced Lung Injury

Imaging Technology

milla1cf Thu, 10/19/2023 - 17:48 October 19, 2023 — The lung is one of the tissues most sensitive to radiation in the human body. Anti-inflammatory drugs given to patients during radiation therapy can dampen the inflammation in the lungs, called pneumonitis, but not all patients respond equally well.

Radiation 111
article thumbnail

ASTRO: Lu-177 dotatate shows promise for treating meningioma patients

AuntMinnie

A radiopharmaceutical therapy that lengthens progression-free survival for patients with neuroendocrine cancer could help treat meningioma sufferers, according to research presented at the American Society for Radiation Oncology (ASTRO) meeting. The researchers also tracked overall survival and rates of adverse events.

article thumbnail

SBRT as Effective as Conventional Radiation for People with Intermediate Risk, Localized Prostate Cancer

Imaging Technology

milla1cf Fri, 09/29/2023 - 17:00 September 29, 2023 — People with intermediate risk, localized prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower doses delivered over several weeks, a new phase III randomized trial suggests.

article thumbnail

SNMMI: Y-90-FAPI-46 more effective for advanced sarcoma

AuntMinnie

After treatment, the investigators documented adverse events of any grade and assessed patients' imaging response via Response Evaluation Criteria in Solid Tumors (RECIST) or PET Response Criteria in Solid Tumors (PERCIST) guidelines. Imaging control of disease by RECIST was obtained in 44% of patients, among which 35% had sarcoma.

article thumbnail

Winners of the ASTRO-Sumitomo Pharma-Pfizer Alliance New Combination Therapy Challenge Announced

Imaging Technology

milla1cf Wed, 09/27/2023 - 15:07 September 27, 2023 — The American Society for Radiation Oncology ( ASTRO ) announced the three winning research proposals for the 2022 ASTRO-Myovant Sciences (now known as Sumitomo Pharma)-Pfizer Alliance New Combination (Relugolix-Radiation) Therapy Challenge.

Radiation 105